theory clinical_107_1
imports Main

begin

typedecl entity
typedecl event

consts
  Overexpression :: "entity ⇒ bool"
  HER2V777LMutation :: "entity ⇒ bool"
  Resistance :: "entity ⇒ bool"
  Trastuzumab :: "entity ⇒ bool"
  Assay :: "entity ⇒ bool"
  ColorectalCancerCellLine :: "entity ⇒ bool"
  Resulted :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "entity ⇒ bool"
  By :: "event ⇒ entity ⇒ bool"
  Tumour :: "entity ⇒ bool"
  AntiHER2AntibodyTherapy :: "entity ⇒ bool"
  Develop :: "event ⇒ bool"
  TrastuzumabTherapy :: "entity ⇒ bool"
  Treatment :: "entity ⇒ bool"
  Benefit :: "event ⇒ bool"
  From :: "event ⇒ entity ⇒ bool"

(* Explanation 1: Overexpression of a HER2 V777L mutation resulted in trastuzumab resistance by a soft-agar colony formation assay of a colorectal cancer cell line. *)
axiomatization where
  explanation_1: "∃x y z e1 e2. Overexpression x ∧ HER2V777LMutation x ∧ Resistance y ∧ Trastuzumab y ∧ Assay z ∧ ColorectalCancerCellLine z ∧ Resulted e1 ∧ Agent e1 x ∧ Patient y ∧ By e2 z"

(* Explanation 2: A portion of tumours ultimately develop resistance to anti-HER2 antibody therapy, including Trastuzumab. *)
axiomatization where
  explanation_2: "∃x y e. Tumour x ∧ Resistance y ∧ AntiHER2AntibodyTherapy y ∧ Trastuzumab y ∧ Develop e ∧ Agent e x ∧ Patient y"

(* Explanation 3: Patients who develop resistance to anti-HER2 antibody therapy may also develop resistance to Trastuzumab therapy. *)
axiomatization where
  explanation_3: "∃x y z e1 e2. Patient x ∧ Resistance y ∧ AntiHER2AntibodyTherapy y ∧ TrastuzumabTherapy z ∧ Develop e1 ∧ Agent e1 x ∧ Patient y ∧ Develop e2 ∧ Agent e2 x ∧ Patient z"

(* Explanation 4: Patient may benefit from treatment with Trastuzumab. *)
axiomatization where
  explanation_4: "∃x y e. Patient x ∧ Treatment y ∧ Trastuzumab y ∧ Benefit e ∧ Agent e x ∧ From e y"

theorem hypothesis:
  assumes asm: "Patient x"
  (* Hypothesis: This patient may develop resistance to Trastuzumab therapy. *)
  shows "∃x y e. Patient x ∧ Resistance y ∧ TrastuzumabTherapy y ∧ Develop e ∧ Agent e x ∧ Patient y"
proof -
  (* From the premise, we have the known information about the patient. *)
  from asm have "Patient x" by simp
  (* Explanation 3 states that patients who develop resistance to anti-HER2 antibody therapy may also develop resistance to Trastuzumab therapy. *)
  (* This is related to logical proposition D: Resistance to Trastuzumab therapy. *)
  (* Explanation 2 provides the link between tumours developing resistance to anti-HER2 antibody therapy and Trastuzumab. *)
  (* Using the logical relation Implies(C, D), we can infer that if a patient develops resistance to anti-HER2 antibody therapy, they may develop resistance to Trastuzumab therapy. *)
  then have "∃y e. Resistance y ∧ TrastuzumabTherapy y ∧ Develop e ∧ Agent e x ∧ Patient y" sledgehammer
  then show ?thesis <ATP>
qed

end
